Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Orion Corporation: Managers' transactions - Eija Ronkainen


Posted on: 03 May 18

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST

Orion Corporation: Managers' transactions - Eija Ronkainen

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Person subject to the notification requirement
Name: Ronkainen, Eija  
Position: Member of the Board/Deputy member
     
Initial Notification  
Reference number: 74370029VAHCXDR7B745_20180503092731_15
     
Issuer
Name: Orion Oyj
LEI: 74370029VAHCXDR7B745
     
Transaction details
Transaction date: 2018-05-02
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Receipt of a Share-Based Incentive or Remuneration
 
Instrument: Share
ISIN: FI0009014377
 
Volume: 697
Unit price: 0.00000
 
Aggregated transactions
Volume: 697
Volume weighted average price: 0.00000

Orion Corporation

Timo Lappalainen Olli Huotari
President and CEO    SVP, Corporate Functions

Publisher:

Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
www.orion.fi

GlobeNewswire
globenewswire.com

Last updated on: 03/05/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.